GE Aerospace (GE) vs Genenta Science S.p.A. (GNTA)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| GE | GNTA | |
|---|---|---|
| Sector | Industrials | Industrials |
| Industry | Aerospace & Defense | Conglomerates |
| Size band | MEGA | NANO |
| Listing | NYSE | Nasdaq CM |
| Country | United States | Italy |
| Theme | aerospace | gene-therapy |
| Price and returns | ||
| Last close | $288.43 | $0.62 |
| Return · 1 week | −7.34% | −5.25% |
| Return · 1 month | −9.23% | −9.51% |
| Return · 3 months | −20.67% | −60.23% |
| Return · year to date | −9.95% | −55.72% |
| Return · 1 year | −7.56% | −81.19% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −25.82% | −93.76% |
| 52-week high | $388.84 | $10.00 |
| 52-week low | $268.91 | $0.55 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $299.26B | $30.11M |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $1.09B | $25.19K |
| Employees | 57,000 | 9 |
| Valuation | ||
| Price to earnings · trailing | 32.64× | n/a (negative earnings) |
| Price to earnings · forward | 30.70× | n/a (negative forward earnings) |
| Price to sales | 5.64× | — |
| Price to book | 16.85× | 0.65× |
| Enterprise value to EBITDA | 26.36× | 0.70× |
| Enterprise value to revenue | 5.82× | — |
| PEG ratio | 3.39 | — |
| Earnings per share · trailing | 8.75 | -0.37 |
| Profitability | ||
| Gross margin | 31.04% | — |
| Operating margin | 18.49% | 0.00% |
| Profit margin | 17.50% | — |
| Return on equity | 50.17% | −38.03% |
| Return on assets | 5.06% | −17.67% |
| Growth | ||
| Revenue growth | +15.90% | — |
| Earnings growth | +8.90% | — |
| Balance sheet and payout | ||
| Debt / equity (%) | 115.99 | 34.81 |
| Current ratio | 0.98 | 14.16 |
| Dividend yield | 0.66% | 0.00% |
| Payout ratio | 20.23% | — |
| Trend and volatility | ||
| RSI · 14 | 29.72 | 36.22 |
| ADX · 14 | 26.56 | 31.39 |
| 50-day average | $321.95 | $0.84 |
| 200-day average | $323.11 | $1.05 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 3.03% | 8.45% |
The full GE analysis
Everything this table leaves out for GE Aerospace: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the GE argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full GE analysisThe full GNTA analysis
Everything this table leaves out for Genenta Science S.p.A.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the GNTA argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full GNTA analysis